Diactin 5 is used to lower blood glucose levels in patients with type II diabetes mellitus
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Glipizide
Conditions to Inform Your Doctor: Liver or kidney problems, Hormonal problems., genetic disorders (e.g., G6PD deficiency), Malnourished, starved, or on an irregular diet.
Avoid alcohol consumption while taking Diactin 5, as it could aggravate your existing condition.
Diactin 5 is generally not recommended for use by pregnant women. Therefore, consult your doctor before taking it.
Diactin 5 is generally not recommended for use by breastfeeding women. Therefore, consult your doctor before taking it.
Diactin 5 does not affect your ability to drive or operate any tools or machines. However, avoid driving or handling heavy tools or machines if your ability is affected by Diactin 5.
Diactin 5 is not recommended for use in patients with kidney problems. Therefore, consult your doctor before taking it.
Diactin 5 is not recommended for use in patients with liver problems. Therefore, consult your doctor before taking it.
It works by increasing the amount of insulin released by the pancreas to lower blood glucose.
The most potential adverse reaction is hypoglycemia (1% to 3.4%). Other reported side effects include asthenia, headache, dizziness, anxiety, tremor, and diarrhea.
Glipizide is indicated as an adjunct to diet for the control of hyperglycemia and its associated symptoms in the treatment of non-insulin-dependent diabetes mellitus (NIDDM type II) when dietary modification has not been proven effective on its own. In certain patients receiving insulin, the concurrent use of Glipizide may permit a reduction in the daily dose of insulin. The use of Glipizide should be recognized by both the physician and patient as a treatment in addition to diet and not as a substitute for diet or as a convenient tool for avoiding dietary restraint. Additionally, short-term administration may be required if diet control alone results in temporary control of blood glucose levels. If satisfactory lowering of blood glucose is no longer achieved during maintenance, the use of Glipizide should be discontinued.
Glipizide lowers blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells. The extrapancreatic effects of Glipizide include an increase in peripheral sensitivity and a reduction in hepatic glucose production.
The hypoglycaemic activity of sulphonylureas may be potentiated by certain drugs, including non-steroidal anti-inflammatory agents and other highly protein-bound drugs (e.g., salicylates, sulphonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and β-adrenergic blocking agents).
Protect from light and moisture by storing below 30°C. Keep the medicine out of children's reach.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.